Inactive Instrument

Cotinga Pharmaceuticals Inc. Toronto S.E.

COT.H

CA22164W1059

Biotechnology & Medical Research

Critical Outcome Technologies Inc. will Change its Name to Cotinga Pharmaceuticals Inc

January 10, 2018 at 10:30 am IST

Effective January 10, 2018, Critical Outcome Technologies Inc. will change its name to Cotinga Pharmaceuticals Inc.

Latest news about Cotinga Pharmaceuticals Inc.

Chart Cotinga Pharmaceuticals Inc.

Duration

Period

More charts

Cotinga Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company. The Company's artificial intelligence platform, CHEMSAS, utilizes a series of predictive computer models to identify compounds with a high probability of being developed from disease specific drug discovery through chemical optimization and preclinical testing. The CHEMSAS platform technology is designed for small molecules, and as a drug candidate discovery engine can be applied to any disease target with information for the target of interest. Its initial focus is in advancing the treatment of cancer with the Company's lead compound, COTI-2, having a p53-dependent mechanism of action demonstrating selective and potent anti- cancer activity.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20.28%	13TCr
REGENERON PHARMACEUTICALS, INC.	+22.94%	12TCr
ARGENX SE	+23.26%	2.79TCr
BIONTECH SE	-18.64%	2.1TCr
GENMAB A/S	-15.13%	1.69TCr
BEIGENE, LTD.	-13.60%	1.62TCr
NEUROCRINE BIOSCIENCES, INC.	+10.31%	1.48TCr
WUXI APPTEC CO., LTD.	-46.10%	1.48TCr
SAREPTA THERAPEUTICS, INC.	+51.69%	1.41TCr

Bio Therapeutic Drugs

Cotinga Pharmaceuticals Inc. Toronto S.E.

Equities

COT.H

CA22164W1059

Biotechnology & Medical Research

Critical Outcome Technologies Inc. will Change its Name to Cotinga Pharmaceuticals Inc

Latest news about Cotinga Pharmaceuticals Inc.

Chart Cotinga Pharmaceuticals Inc.

Company Profile

Sector Bio Therapeutic Drugs